Jiangsu Hengrui Medicine Co., Ltd.
600276
Clasificación en acciones
#544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Precio por acción
$6.89
Capitalización bursátil
$43.94B
Cambio (1 día)
-2.91%
Cambio (1 año)
-24.78%
País
CN
Comercio Jiangsu Hengrui Medicine Co., Ltd. (600276)
Categoría
Healthcare
Número de acciones en circulación de Jiangsu Hengrui Medicine Co., Ltd. (600276)
Número de acciones en circulación al October 2026: 0
Según los últimos informes financieros y el precio de las acciones de Jiangsu Hengrui Medicine Co., Ltd., el número actual de acciones en circulación es 0. Al final de October 2026, la empresa tenía 0 acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Jiangsu Hengrui Medicine Co., Ltd. (600276) desde 2001 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2025 | 6.50B | 2.58% |
| 2024 | 6.34B | 0.15% |
| 2023 | 6.33B | -0.63% |
| 2022 | 6.37B | -0.21% |
| 2021 | 6.38B | 0.38% |
| 2020 | 6.36B | 0.31% |
| 2019 | 6.34B | -0.42% |
| 2018 | 6.36B | 1.14% |
| 2017 | 6.29B | -0.45% |
| 2016 | 6.32B | -0.18% |
| 2015 | 6.33B | 0.46% |
| 2014 | 6.30B | -0.11% |
| 2013 | 6.31B | 0.29% |
| 2012 | 6.29B | -0.01% |
| 2011 | 6.29B | 0.36% |
| 2010 | 6.27B | 0.00% |
| 2009 | 6.27B | 0.26% |
| 2008 | 6.25B | -0.01% |
| 2007 | 6.25B | 0.00% |
| 2006 | 6.25B | 87.25% |
| 2005 | 3.34B | 0.00% |
| 2004 | 3.34B | 0.00% |
| 2003 | 3.34B | 0.00% |
| 2002 | 3.34B | 0.00% |
| 2001 | 3.34B | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
